In the current month of November, IMEXHS has been working hand in hand with Eberco Comunicaciones on the business plan that will allow the company to enter the Brazilian market.

Since IMEXHS received the ANVISA Certification of Good Practices for the Manufacture of Class II Medical Devices from the Brazilian National Health Surveillance Agency last September, it has decided to establish a new partnership with Eberco Communications, which will provide advice on strategic planning and everything related to its business strategy in Brazil, as well as communication and marketing consulting. Both companies will be focused on understanding the Brazilian market to take firm steps in this new territory and enter successfully.

This project, which began on 1 November 2020, will be fundamental in the introduction of IMEXHS to the Brazilian market by ensuring that the company has a high probability of reception and recognition in one of the most important markets in our region.

IMEXHS will enter the Brazilian market with its Aquila 3.0 product through the Aquila in the Cloud business model, which is hosted within Microsoft Azure. AiC can be implemented quickly in multiple geographies, where clients pay a connection and setup fee for the software service with ongoing usage charges per studio. Vitrea’s advanced post-processing tools, provided by Canon Group, are also available to AiC clients. This provides small to medium-sized clients with access to sophisticated advanced imaging tools on a per-study basis, which helps reduce overall costs while improving patient outcomes.